Vernalis Stock Price (OTCMKTS:VNLPY)

Add to My Stocks
$0.76 $0 (0%) VNLPY stock closing price Jan 20, 2017 (Closing)
Prev Close* : $0.76
Market Cap:
$200.01M
Day Low: $0
52 Week Low: $0.76
Open: $0
Volume: 0
Day High: $0
52 Week High: $1.70
Dividend:
N/A

Latest Stock Market News

Latest Articles

VNLPY Stockcharts

View VNLPY PE ratio, PS ratio stocks charts and compare with peers.
VNLPY Chart
Note: Compare Vernalis stock price history with the index and industry peers.

VNLPY Industry Peers

Company Price Change (%)
Immunogen (IMGN)2.430.05 (2.02%)
Ocular Therapeutix (OCUL)7.930.23 (2.82%)
Cti Biopharma (CTIC)4.970.1 (1.97%)
H. Lundbeck (HLUYY)41.940.55 (1.29%)
Biotie Therapies (BITI)25.80.71 (2.68%)
Astrazeneca (AZN)27.070.84 (3.01%)
Glaxosmithkline (GSK)38.720.03 (0.08%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Aralez Pharma (ARLZ)4.40.34 (8.37%)
Concert Pharma (CNCE)9.370.52 (5.88%)
AVADEL PHARMA (AVDL)10.310.4 (4.04%)
Nutraceutical International (NUTR)34.80.4 (1.16%)
Aratana Therapeutics (PETX)7.620.08 (1.06%)
La Jolla Pharma (LJPC)20.130.2 (1%)
Zoetis (ZTS)53.970.47 (0.88%)
Top gainers from Medical-Drugs industry
* As of Jan 21, 2017
CompanyPriceChange (%)
Synergy Pharma (SGYP)5.910.5 (7.8%)
Achaogen (AKAO)17.551.29 (6.85%)
Cempra (CEMP)30.2 (6.25%)
Xencor (XNCR)21.741.01 (4.44%)
Endo International (ENDP)12.340.56 (4.34%)
Egalet (EGLT)5.020.22 (4.2%)
Durect (DRRX)1.180.05 (4.07%)
Top losers from Medical-Drugs industry
* As of Jan 21, 2017

Vernalis Financial Statements

income statement20162013201220112010
Net Sales Or Revenues17.86M22.04M23.16M19.5M21.95M
Net Income-21.51M-6.26M-8.31M-12.31M-30.39M
Total Operating Expense-27.43M28.88M33.49M39.86M
view Vernalis plc (ADR) income statement
balance sheet20142013201220112010
Total Assets145.9M152.08M154.24M58.63M82.18M
Total Liabilities14.55M13.83M16.28M18.82M17.52M
Shareholders Equity131.35M138.25M137.95M39.81M64.66M
view Vernalis plc (ADR) balance sheet

Vernalis Stock Message Board

As of last trading day, Vernalis stock price was 0.76. Vernalis market capitalization is 200.01M and it represents the total market value of VNLPY stock. A value investor must look at the fundamentals of a stock, and perform Vernalis valuation, even though in the short-term sentiment and current breaking news might affect Vernalis stock price.

For recognizing and analyzing the real performance of Vernalis stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. 0 VNLPY shares were traded yesterday, and Vernalis stock chart shows that the VNLPY stock quote hit a day high of 0 and day low of 0. A dividend is a cash payment from a company's earnings and is distributed among shareholders. Vernalis does not pay dividends. Vernalis stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.